| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/14/2002 | US20020018831 Process for the continuous isolation of active proteins |
| 02/14/2002 | US20020018784 Vaccine against mumps containing a jeryl-lynn virus strain |
| 02/14/2002 | US20020018782 Binding to antibodies; prophylaxis, therapy of infections |
| 02/14/2002 | US20020018781 Drugs, vaccines |
| 02/14/2002 | US20020018780 Administering protein, polypeptide containing neutralizing antibodies |
| 02/14/2002 | US20020018779 Non-anaphylactic forms of allergens and their use |
| 02/14/2002 | US20020018778 Passive desensitization |
| 02/14/2002 | US20020018769 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 02/14/2002 | US20020018765 Genetic engineering; transforming genes; Dna viruses |
| 02/14/2002 | US20020018751 Cellular and serum protein anchors for diagnostic imaging |
| 02/14/2002 | US20020018749 High avidity polyvalent and polyspecific reagents |
| 02/14/2002 | DE10038237A1 Verfahren zum Nachweis von Mutationen in Nucleotidsequenzen A method for detecting mutations in nucleotide sequences |
| 02/14/2002 | DE10037270A1 Silicatein-vermittelte Synthese von amorphen Silikaten und Siloxanen und ihre Verwendung Silicatein-mediated synthesis of amorphous silicates and siloxanes and their use |
| 02/14/2002 | DE10031740A1 Künstliche Sauerstoffträger aus vernetztem modifizierten Human- oder Schweinehämoglobin mit verbesserten Eigenschaften, Verfahren zu ihrer technisch einfachen Herstellung aus gereinigtem Material in hohen Ausbeuten, sowie deren Verwendung Artificial oxygen carriers from cross-linked modified human or porcine hemoglobin with improved properties, methods for their technically simple preparation of purified material in high yields, and their use |
| 02/14/2002 | CA2820132A1 2,5-dkg permeases |
| 02/14/2002 | CA2423519A1 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 02/14/2002 | CA2419052A1 Potential growth factors from the human tumour cell line ht1080 |
| 02/14/2002 | CA2419019A1 Pseudo-metalloproteins, corresponding preparation and use as biosensors |
| 02/14/2002 | CA2418950A1 Soluble zcytor 11 cytokine receptors |
| 02/14/2002 | CA2418936A1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 02/14/2002 | CA2418913A1 Peptide mimetics |
| 02/14/2002 | CA2418834A1 Iapl-3 a protein inhibitor of apoptosis proteins |
| 02/14/2002 | CA2418779A1 Schizophrenia related gene and protein |
| 02/14/2002 | CA2418746A1 Gene expression from the internal ribosome entry site (ires) of rhopalosiphum padi virus (rhpv) |
| 02/14/2002 | CA2418445A1 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | CA2418386A1 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | CA2418383A1 Radiolabelled metal transport proteins as imaging agents |
| 02/14/2002 | CA2418144A1 Urocortin proteins and uses thereof |
| 02/14/2002 | CA2418091A1 Virus-like particles and process for producing the same |
| 02/14/2002 | CA2417970A1 2,5-dkg permeases |
| 02/14/2002 | CA2417969A1 Enhancement of industrial production by increasing substrate transport |
| 02/14/2002 | CA2417915A1 Her-2/neu fusion proteins |
| 02/14/2002 | CA2417909A1 Isolation and use of solid tumor stem cells |
| 02/14/2002 | CA2417888A1 Split-ubiquitin based reporter systems and methods of their use |
| 02/14/2002 | CA2417868A1 An isolated yeast promoter sequence and a method of regulated heterologous expression |
| 02/14/2002 | CA2417866A1 Compositions and methods for the therapy and diagnosis of colon cancer |
| 02/14/2002 | CA2417707A1 Sid.rtm. nucleic acids and polypeptides selected from a pathogenic strain of hepatitis c virus and applications thereof |
| 02/14/2002 | CA2417676A1 Sequences for integrin alpha-8 |
| 02/14/2002 | CA2417589A1 Motor proteins and methods for their use |
| 02/14/2002 | CA2417587A1 Transporters and ion channels |
| 02/14/2002 | CA2417368A1 Suppressor gene |
| 02/14/2002 | CA2417357A1 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
| 02/14/2002 | CA2417310A1 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease |
| 02/14/2002 | CA2417214A1 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
| 02/14/2002 | CA2416982A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 02/14/2002 | CA2416890A1 Therapeutic anti-melanoma compounds |
| 02/14/2002 | CA2415868A1 Systems and methods for authenticating a user to a web server |
| 02/14/2002 | CA2415333A1 Adenovirus e1b-55k single amino acid mutants and methods of use |
| 02/14/2002 | CA2386103A1 Vascular endothelial growth factor 2 |
| 02/13/2002 | EP1179733A1 Compounds and methods for diagnosis of leishmaniasis |
| 02/13/2002 | EP1179594A1 Rnp originating in paramyxovirus |
| 02/13/2002 | EP1179593A1 Process for producing recombinant insulin from novel fused protein |
| 02/13/2002 | EP1179592A1 Proteins nectin-3 |
| 02/13/2002 | EP1179591A1 Sodium ion-driven chloride/bicarbonate exchanger |
| 02/13/2002 | EP1179590A1 Meg-3 protein |
| 02/13/2002 | EP1179589A1 MMX-1, a member of the family of human cancer/testis antigens, a protein encoded thereby and a process for determining whether a tumor sample has metastatic potential |
| 02/13/2002 | EP1179588A1 Human brain carboxypeptidase b |
| 02/13/2002 | EP1179541A1 Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 02/13/2002 | EP1179540A1 Novel polypeptide |
| 02/13/2002 | EP1179539A1 Novel protein having hemolytic activity and gene encoding the protein |
| 02/13/2002 | EP1179538A1 Peptides blocking response to chemical substances or thermal stimuli or nociceptor inflammation mediators and compositions containing said peptides |
| 02/13/2002 | EP1179350A2 Encapsulated cell system for implantation into the human CNS |
| 02/13/2002 | EP1179348A2 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases |
| 02/13/2002 | EP1179347A1 Liver function controlling agents |
| 02/13/2002 | EP1179186A2 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction |
| 02/13/2002 | EP1179182A2 Diagnosis and treatment of atherosclerosis and coronary heart disease |
| 02/13/2002 | EP1179179A1 Use of an antibody to detect basophiles and/or mast cells |
| 02/13/2002 | EP1179095A1 Methods for producing modified nucleic acid molecules |
| 02/13/2002 | EP1179094A2 Assay for the detection of paclitaxel resistant cells in human tumors |
| 02/13/2002 | EP1179083A1 Triple hybrid amplicon vector systems to generate retroviral packaging lines |
| 02/13/2002 | EP1179082A2 Improved retroviral production by inhibition of the enveloppe cell receptor |
| 02/13/2002 | EP1179080A1 The maize rs324 promoter and methods for use thereof |
| 02/13/2002 | EP1179072A2 Combination neisserial compositions |
| 02/13/2002 | EP1179071A2 Regulating organelle homeostasis in a cell factory |
| 02/13/2002 | EP1179070A2 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants |
| 02/13/2002 | EP1179069A1 GENE ISOLATED FROM $i(RICINUS COMMUNIS) ENCODING A NEW PROTEIN THAT INTERACTS WITH THE OLEATE 12-HYDROXYLASE ENZYME |
| 02/13/2002 | EP1179068A1 Interleukin-1 hy2 materials and methods |
| 02/13/2002 | EP1179067A1 Neuroprotective properties of gdf-15, a novel member of the tgf-beta superfamily |
| 02/13/2002 | EP1179066A2 Extracellular signaling molecules |
| 02/13/2002 | EP1179065A2 Full-length molecules expressed in human tissues |
| 02/13/2002 | EP1179064A2 Secreted polypeptides and corresponding polynucleotides |
| 02/13/2002 | EP1179063A2 Genes expressed in hippocampus |
| 02/13/2002 | EP1179062A2 Nucleic acids and proteins with p53 activity and altered tetramerization domains |
| 02/13/2002 | EP1179061A1 Methods for treating tumors using antiangiogenic compounds |
| 02/13/2002 | EP1179059A1 Isolating biological modulators from biodiverse gene fragment libraries |
| 02/13/2002 | EP1179054A2 Use of recombinant parainfluenza viruses (pivs) as vectors to protect against infection and disease caused by piv and other human pathogens |
| 02/13/2002 | EP1179052A2 Serine proteases |
| 02/13/2002 | EP1179049A2 (ex vivo) expansion of mammalian hematopoietic stem cells |
| 02/13/2002 | EP1179022A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179020A1 Low-dose il-1beta-induced photoreceptor cell rescue without retinal dysplasia |
| 02/13/2002 | EP1179019A2 Immunogenic peptides derived from mage and the use thereof |
| 02/13/2002 | EP1179018A1 Interaction between the vhl tumour suppressor and hypoxia inducible factor, and assay methods relating thereto |
| 02/13/2002 | EP1179017A1 Expression of heparin-binding protein in recombinant mammalian cells |
| 02/13/2002 | EP1179016A1 Parasite antigens |
| 02/13/2002 | EP1179015A1 Dna molecules encoding human clax proteins and their soluble fusion proteins |
| 02/13/2002 | EP1179014A1 Derivatives of the b or z domain from staphylococcal protein a (spa) interacting with at least one domain of human factor viii |
| 02/13/2002 | EP1179013A1 Protein scaffold and its use to multimerise monomeric polypeptides |
| 02/13/2002 | EP1179012A1 Long lasting fusion peptide inhibitors or viral infection |
| 02/13/2002 | EP1179010A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179007A1 Self-assembling biomolecular structures |